Device / Technology News

RSS

Clearside Biomedical receives $4M venture capital investment

Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.

6 Jan 2012

Photoacoustic device can detect melanoma cancer at cellular level

Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies.

6 Jan 2012

SonoPhoto Dynamic Therapy shows promise against squamous cell carcinoma

George Miller developed an ulcer on his bottom lip that began to bleed. His doctor sent cell scrapings to a pathologist, and diagnosed Miller with squamous cell carcinoma (SCC). According to TMD Limited, a medical tourism company, squamous cell carcinoma is the 2nd most common cancer in humans and other animals.

6 Jan 2012

Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

From Evident Corporation - Life Sciences 6 Jan 2012

LCA calls for more aggressive integration of imaging advances and biomedical research

As the War on Cancer enters its fifth decade and the number of people being diagnosed with cancer continues to rise, Lung Cancer Alliance (LCA) called for more aggressive integration of advanced imaging technology and biomedical research to improve prevention, earlier detection and treatment of cancer.

6 Jan 2012

FSU, First Signs and Autism Speaks introduce new treatment section of Video Glossary

Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.

6 Jan 2012

Jena chemists develop novel glass ceramics for dentistry

The hardest substance in the human body is moved by its strongest muscles: When we heartily bite into an apple or a schnitzel, enormous strengths are working on the surface of our teeth. "What the natural tooth enamel has to endure also goes for dentures, inlays or bridges", glass chemist Prof. Dr. Dr. Christian R-ssel of the Friedrich Schiller University Jena says.

5 Jan 2012

FDA asks makers of vaginal mesh to respond to safety queries

The U.S. Food and Drug Administration (FDA) has ordered Johnson & Johnson and C.R. Bard Inc. to study rates of organ damage, infection and painful sex linked to vaginal mesh implants, in response to doctors and patients who say the devices have harmed women.

5 Jan 2012

Postpartum Support International unveils new Spanish language educational DVD

Postpartum Support International Unveils New Spanish Language Educational DVD "MADRE SALUDABLE, FAMILIA FELIZ" Offered to Hospitals & Healthcare Agencies Nationwide As Part of Clinical Training & Education Program Helping Alleviate the #1 Complication of Child Birth: Untreated Depression

5 Jan 2012

Boulder Diagnostics, RUNMC enter agreement to market Lyme disease diagnostic test

Boulder Diagnostics Inc. and the Department of Internal Medicine, Radboud University Nijmegen Medical Centre announced today the entry into a license and collaboration agreement to market the innovative Lyme disease diagnostic test developed at RUNMC.

5 Jan 2012

Healthfirst to implement MedAssurant's Star Advantage solution

MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.

5 Jan 2012

CMS acknowledges clinical improvement linked with use of Alair Bronchial Thermoplasty System

Boston Scientific Corporation announced that the Centers for Medicare and Medicaid Services (CMS), the agency that administers the Medicare program, has acknowledged the substantial clinical improvement associated with the use of the Alair Bronchial Thermoplasty System to perform bronchial thermoplasty for the management of severe asthma.

5 Jan 2012

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle.

5 Jan 2012

ACP's Medical Home Builder 2.0 tool available free to PCMH practices

CareFirst BlueCross BlueShield (CareFirst) today announced that it has joined with the American College of Physicians (ACP) to make available the ACP's Medical Home Builder- 2.0 (MHB 2.0) tool to participating CareFirst Patient-Centered Medical Home (PCMH) practices.

5 Jan 2012

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Itamar-Medical, the world's leader of non-invasive devices for diagnosis of cardiovascular health, announced achievement of the next milestone of the international pharmaceutical company, Roche, to further develop the EndoPAT technology for pre-clinical trials.

5 Jan 2012

JHTR, COMBI introduce 'Tools for Clinical Use'

Starting this month, The Journal of Head Trauma Rehabilitation (JHTR)—in partnership with The Center For Outcome Measurement in Brain Injury (COMBI)—introduces a new feature designed to support effective and informed use of standardized assessments for evaluation of brain injury.

5 Jan 2012

Free public lecture to look at role of stents in treating coronary artery diseases

State-of-the art treatments for patients with heart problems are the theme of a public lecture at the University of Greenwich this month. The lecture, which is free and open to all, will look at the role of stents in treating coronary artery diseases. A stent is a tiny, artificial tube which is placed in the coronary arteries that supply the heart: by keeping the arteries open, the stent combats the effects of reduced blood flow, such as blood clots.

5 Jan 2012

New algorithm could help GPs identify women at risk of early ovarian cancer

The lives of hundreds of women could be saved every year, thanks to a simple online calculator that could help GPs identify women most at risk of having ovarian cancer at a much earlier stage.

5 Jan 2012

Medtronic introduces mySentry Remote Glucose Monitor in the U.S.

Today, Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval and U.S. market launch of the first-of-its-kind mySentry Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient's MiniMed Paradigm REAL-Time Revel System.

From Medtronic 4 Jan 2012

St. Jude Medical meets stopping rule in RESPECT clinical trial, closes patient enrollment

St. Jude Medical, Inc., a global medical device company, today announced that it has met a stopping rule in its RESPECT clinical trial - triggered by reaching the protocol-required number of primary events in the trial, defined as stroke and all-cause mortality - and is closing patient enrollment.

4 Jan 2012